Assessing the Policy Environment for Active Mobility in Cities-Development and Feasibility of the PASTA Cycling and Walking Policy Environment Score.

active travel policy assessment cycling scoring transport planning walking

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
22 01 2021
Historique:
received: 14 12 2020
revised: 12 01 2021
accepted: 13 01 2021
entrez: 27 1 2021
pubmed: 28 1 2021
medline: 24 4 2021
Statut: epublish

Résumé

The importance of setting a policy focus on promoting cycling and walking as sustainable and healthy modes of transport is increasingly recognized. However, to date a science-driven scoring system to assess the policy environment for cycling and walking is lacking. In this study, spreadsheet-based scoring systems for cycling and walking were developed, including six dimensions (cycling/walking culture, social acceptance, perception of traffic safety, advocacy, politics and urban planning). Feasibility was tested using qualitative data from pre-specified sections of semi-standardized interview and workshop reports from a European research project in seven cities, assessed independently by two experts. Disagreements were resolved by discussions of no more than 75 minutes per city. On the dimension "perception of traffic safety", quantitative panel data were used. While the interrater agreement was fair, feasibility was confirmed in general. Validity testing against social norms towards active travel, modal split and network length was encouraging for the policy area of cycling. Rating the policy friendliness for cycling and walking separately was found to be appropriate, as different cities received the highest scores for each. Replicating this approach in a more standardized way would pave the way towards a transparent, evidence-based system for benchmarking policy approaches of cities towards cycling and walking.

Identifiants

pubmed: 33499420
pii: ijerph18030986
doi: 10.3390/ijerph18030986
pmc: PMC7908172
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Lancet. 2016 May 28;387(10034):2207-17
pubmed: 27045735
Prev Med. 2018 Apr;109:62-70
pubmed: 29330030
Lancet. 2009 Dec 5;374(9705):1930-43
pubmed: 19942277
Int J Behav Nutr Phys Act. 2014 Oct 24;11:132
pubmed: 25344355
Int J Behav Nutr Phys Act. 2019 Oct 7;16(1):84
pubmed: 31590666
J Phys Act Health. 2014 Feb;11(2):233-40
pubmed: 23364305
Lancet Glob Health. 2018 Oct;6(10):e1077-e1086
pubmed: 30193830
BMJ Open. 2016 Jan 07;6(1):e009924
pubmed: 26743706
Int J Behav Nutr Phys Act. 2015 Feb 28;12:30
pubmed: 25886356
BMC Public Health. 2015 Nov 14;15:1126
pubmed: 26577129
Lancet. 2016 Sep 24;388(10051):1325-36
pubmed: 27475270

Auteurs

Sonja Kahlmeier (S)

Department of Health, Swiss Distance University of Applied Science (FFHS), 3900 Brig, Switzerland.
Biostatistics and Prevention Institute (EBPI), Epidemiology, University of Zurich, 8001 Zurich, Switzerland.

Esther Anaya Boig (EA)

Centre for Environmental Policy, Imperial College London, London SW7 1NE, UK.

Castro Fernandez A (C)

Biostatistics and Prevention Institute (EBPI), Epidemiology, University of Zurich, 8001 Zurich, Switzerland.

Emilia Smeds (E)

Technology, Engineering and Public Policy (STEaPP), Department for Science, University College London, London WC1E 6JA, UK.

Fabrizio Benvenuti (F)

Roma Servizi per la mobilità, 00143 Rome, Italy.

Ulf Eriksson (U)

Trivector, 11123 Stockholm, Sweden.

Francesco Iacorossi (F)

Roma Servizi per la mobilità, 00143 Rome, Italy.

Mark J Nieuwenhuijsen (MJ)

Institute for Global Health (IS Global), 08003 Barcelona, Spain.

Luc Int Panis (L)

Flemish Institute for Technological Research VITO, 2400 Mol, Belgium.
School for Mobility, Hasselt University, 3500 Hasselt, Belgium.

David Rojas-Rueda (D)

Barcelona Institute for Global Health (ISGlobal), 08003 Barcelona, Spain.
Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO 80523-1601, USA.

Sandra Wegener (S)

Institute for Transport Studies (ITS-), University of Natural Resources and Life Sciences BOKU, 1180 Vienna, Austria.

Audrey de Nazelle (A)

Centre for Environmental Policy, Imperial College London, London SW7 1NE, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH